Total planned funding: $90,976,968
Allocations
Countries/Regions
| Central Asia Region | $90,976,968 |
Organizational Types
| Own Agency | $30,995,124 |
| Unknown | $19,141,387 |
| University | $15,347,792 |
| NGO | $10,499,169 |
| Host Country Government Agency | $8,098,267 |
| Private Contractor | $4,282,129 |
| Multi-lateral Agency | $2,265,000 |
| Other USG Agency | $181,100 |
| Implementing Agency | $167,000 |
Program Areas
| Prevention | $27,381,805 |
| Management and Operations | $22,194,267 |
| Governance and Systems | $18,670,593 |
| Care | $10,568,550 |
| Treatment | $6,212,990 |
| Testing | $5,948,763 |
Budget Codes
| HVMS: Management and Operations | $22,194,267 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $20,297,222 |
| HBHC: Care: Adult Care and Support | $9,061,533 |
| HLAB: Laboratory Infrastructure | $7,157,289 |
| HTXS: Treatment: Adult Treatment | $6,153,801 |
| HVCT: Testing: HIV Testing and Counseling | $5,948,763 |
| HVSI: Strategic Information | $5,935,769 |
| OHSS: Health Systems Strengthening | $5,577,535 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,204,478 |
| HVTB: Care: TB/HIV | $1,507,017 |
| HMBL: Biomedical Prevention: Blood Safety | $1,405,750 |
| HMIN: Biomedical Prevention: Injection Safety | $474,355 |
| HTXD: Treatment: ARV Drugs | $59,189 |
Top Partner Programs
USG Aggregated Agencies:
$19,855,761
Countries/Regions
Not Available:
$19,041,387
Countries/Regions
Columbia University:
$15,347,792
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
| 2013 | $3,238,500 |
| 2014 | $2,983,204 |